These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9570470)

  • 1. Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system.
    Cotter MA; Cameron NE
    Eur J Pharmacol; 1998 Feb; 343(2-3):217-23. PubMed ID: 9570470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M; Omawari N; Tomlinson DR
    Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovascular effects of L-carnitine treatment in diabetic rats.
    Cameron NE; Cotter MA
    Eur J Pharmacol; 1997 Jan; 319(2-3):239-44. PubMed ID: 9042596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
    Cameron NE; Cotter MA; Hohman TC
    Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats.
    Cameron NE; Cotter MA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):685-90. PubMed ID: 9053742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline effects on nerve conduction velocity and blood flow in diabetic rats.
    Flint H; Cotter MA; Cameron NE
    Int J Exp Diabetes Res; 2000; 1(1):49-58. PubMed ID: 11469390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.
    Cotter MA; Ekberg K; Wahren J; Cameron NE
    Diabetes; 2003 Jul; 52(7):1812-7. PubMed ID: 12829651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR; Dewhurst M; Stevens EJ; Omawari N; Carrington AL; Vo PA
    Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
    Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
    Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.
    Yoshida M; Sugiyama Y; Akaike N; Ashizawa N; Aotsuka T; Ohbayashi S; Matsuura A
    Diabetes Res Clin Pract; 1998 May; 40(2):101-12. PubMed ID: 9681275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK
    Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.
    Pourageaud F; Leblais V; Bellance N; Marthan R; Muller B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):14-23. PubMed ID: 16133491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats.
    Cameron NE; Cotter MA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):607-14. PubMed ID: 12743678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of potassium channels and nitric oxide in the relaxant effects elicited by beta-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat.
    Dumas JP; Goirand F; Bardou M; Dumas M; Rochette L; Advenier C; Giudicelli JF
    Br J Pharmacol; 1999 May; 127(2):421-8. PubMed ID: 10385242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide.
    Amour J; Loyer X; Le Guen M; Mabrouk N; David JS; Camors E; Carusio N; Vivien B; Andriantsitohaina R; Heymes C; Riou B
    Anesthesiology; 2007 Sep; 107(3):452-60. PubMed ID: 17721248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.
    Stevens MJ; Dananberg J; Feldman EL; Lattimer SA; Kamijo M; Thomas TP; Shindo H; Sima AA; Greene DA
    J Clin Invest; 1994 Aug; 94(2):853-9. PubMed ID: 8040341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
    Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats.
    Jack AM; Cameron NE; Cotter MA
    J Diabetes Complications; 1999; 13(1):2-9. PubMed ID: 10232703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.